The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zabrodskaya Yu.M.

Prof. A.L. Polenov Russian Research Institute of Neurosurgery — Branch V.A. Almazov National Medical Research Center of the Ministry of Health of Russia

Sidorin V.S.

Polenov Neurosurgical Institute — the branch of Almazov National Medical Research Centre

Nikolaenko M.S.

Polenov Neurosurgical Institute — the branch of Almazov National Medical Research Centre

Samochernykh K.A.

Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute

Tumor progression of diffuse median glioma with H3 K27 alteration from pilocytic astrocytoma to glioblastoma

Authors:

Zabrodskaya Yu.M., Sidorin V.S., Nikolaenko M.S., Samochernykh K.A.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2022;84(6): 40‑46

DOI: 10.17116/patol20228406140

Read: 6288 times

Download PDF (RU)
Contact the author
Table of contents

TUMOR PROGRESSION OF DIFFUSE MEDIAN GLIOMA WITH H3 K27 ALTERATION FROM PILOCYTIC ASTROCYTOMA TO GLIOBLASTOMA
TUMOR PROGRESSION OF DIFFUSE MEDIAN GLIOMA WITH H3 K27 ALTERATION FROM PILOCYTIC ASTROCYTOMA TO GLIOBLASTOMA

To cite this article:

Zabrodskaya YuM, Sidorin VS, Nikolaenko MS, Samochernykh KA. Tumor progression of diffuse median glioma with H3 K27 alteration from pilocytic astrocytoma to glioblastoma. Russian Journal of Archive of Pathology. 2022;84(6):40‑46. (In Russ.)
https://doi.org/10.17116/patol20228406140

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pathology features of recu­rrent meni­ngioma. Russian Journal of Archive of Pathology. 2025;(5):28-35
A Novel Rat Glioblastoma 101/8 Model: A Comparative PET-CT Study with C6 Rat model. Burdenko's Journal of Neurosurgery. 2024;(6):54-62
Anti­gen rece­ptors in the deve­lopment of CAR-T cells for glioblastoma immu­notherapy. P.A. Herzen Journal of Onco­logy. 2024;(6):91-95
The choice of radiotherapy dose fractionation regi­men for grade 4 gliomas depe­nding on the status of MGMT. P.A. Herzen Journal of Onco­logy. 2025;(1):13-18
Radiation therapy with focal dose esca­lation in the treatment of glioblastoma. P.A. Herzen Journal of Onco­logy. 2025;(2):64-69
Glymphatic system in health and disease: a narrative review. Burdenko's Journal of Neurosurgery. 2025;(4):112-118
TERTp muta­tion screening using digi­tal droplet PCR of collection of 52 paired DNA samples from blood plasma and tumor tissue in patients with glioblastoma. Burdenko's Journal of Neurosurgery. 2025;(5):87-95
Fluorescence navi­gation and endo­scopic assi­stance in surgery for brain glioblastomas. Burdenko's Journal of Neurosurgery. 2025;(6):28-37
Abstract:

In the latest revisions of the WHO Classification of CNS Tumors, carried out in 2016 and 2021, the traditional histogenetic classification of gliomas is rebuilt on a new molecular genetic basis, according to which diffuse midline glioma with alteration of histone H3 K27 is distinguished as a specific pediatric oncosyndrome. The rationale was the association of this feature of midline gliomas in children with a worse prognosis and the prospective possibilities of targeted therapy. A thematic review of the literature and our own observation of H3 K27M-positive glioma in the area of the right thalamus in a 6-year-old child, which initially had the appearance of pilocytic astrocytoma, recurred three times (within 1.5 years) and underwent tumor progression with anaplastic transformation into diffuse glioma of the glioblastoma type, are presented. The authors are inclined to believe that although the determination of the molecular genetic status of H3 K27 provides important information regarding the probable prognosis, at the same time there is no reason to doubt that histological verification should continue to be the basis of oncological diagnosis.

Keywords:

pediatric oncopathology
classification of CNS tumors
H3K27 mutation
tumor progression
pilocytic astrocytoma
glioblastoma

Authors:

Zabrodskaya Yu.M.

Prof. A.L. Polenov Russian Research Institute of Neurosurgery — Branch V.A. Almazov National Medical Research Center of the Ministry of Health of Russia

Sidorin V.S.

Polenov Neurosurgical Institute — the branch of Almazov National Medical Research Centre

Nikolaenko M.S.

Polenov Neurosurgical Institute — the branch of Almazov National Medical Research Centre

Samochernykh K.A.

Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute

Received:

07.06.2022

Accepted:

21.09.2022

Close metadata

References:

  1. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013—2017. Neuro Oncol. 2020;22(12 suppl 2):iv1-iv96. https://doi.org/10.1093/neuonc/noaa200
  2. Ulitin AYu, Matsko DE, Olyushin VE. Neuroepithelial brain tumors. SPb.: Sintez Buk; 2014. (In Russ.).
  3. Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E, Bartels U, et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet. 2014;46(5):451-456.  https://doi.org/10.1038/ng.2936
  4. Merishavyan AA, Papusha LI, Valiakhmetova EF, Drui AE, Yas’ko LA, Brilliantova VV, Artemov AV, Karachunskii AI. A case report of pilocytic astrocytoma of the brainstem. Pediatric Hematology/Oncology and Immunopathology. 2020;19(4):120-124. (In Russ.). https://doi.org/10.24287/1726-1708-2020-19-4-120-124
  5. Dorfer C, Czech T, Gojo J, Hosmann A, Peyrl A, Azizi AA, Kasprian G, Dieckmann K, Filbin MG, Haberler C, et al. Infiltrative gliomas of the thalamus in children: the role of surgery in the era of H3 K27M mutant midline gliomas. Acta Neurochir (Wien). 2021;163(7):2025-2035. https://doi.org/10.1007/s00701-020-04589-y
  6. Caretti V, Bugiani M, Freret M, Schellen P, Jansen M, van Vuurden D, Kaspers G, Fisher PG, Hulleman E, Wesseling P, et al. Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathol. 2014;128(4):605-607.  https://doi.org/10.1007/s00401-014-1307-x
  7. Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol. 2014;128(4):573-581.  https://doi.org/10.1007/s00401-014-1319-6
  8. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012;124(3):439-447.  https://doi.org/10.1007/s00401-012-0998-0
  9. Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, Pagès M, Taylor KR, Saulnier P, Lacroix L, et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol. 2015;130(6):815-827.  https://doi.org/10.1007/s00401-015-1478-0
  10. Kleinschmidt-DeMasters BK, Mulcahy Levy JM. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol. 2018;37(2018)(2):53-63.  https://doi.org/10.5414/NP301085
  11. Lu VM, Alvi MA, McDonald KL, Daniels DJ. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis. J Neurosurg Pediatr. 2018;23(3):308-316.  https://doi.org/10.3171/2018.9.PEDS18419
  12. Hawkins C, Ellison DW, Sturm D. Diffuse midline glioma, H3 K27M-mutant. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO classification of tumours of the central nervous system. 4th ed., revised. Vol. 1. Lion: IARC; 2016;57-59. 
  13. Sitovskaya DA, Sokolova TV, Kurnosov IA, Zabrodskaya YuM. Diffuse midline glioma with H3 K27M mutation: literature review and own observations. Onkopatologiya = Oncopathology. 2021;4(1-2):49-57. (In Russ.). https://doi.org/10.17650/2618-7019-2021-4-1-2-49-57
  14. Alzoubi H, Maraqa B, Hasasna N, Giangaspero F, Antonelli M, Gianno F, Arcella A, Al-Hussaini M. Diffuse midline glioma H3 K27M-mutant in adults: a report of six cases and literature review. Clin Neuropathol. 2021;40(2):108-117.  https://doi.org/10.5414/NP301331
  15. Grimaldi S, Harlay V, Appay R, Bequet C, Petrirena G, Campello C, Barrié M, Autran D, Boissonneau S, Graillon T, et al. Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients. J Neurooncol. 2022;156(3):615-623.  https://doi.org/10.1007/s11060-022-03943-7
  16. Gessi M, Capper D, Sahm F, Huang K, von Deimling A, Tippel S, Fleischhack G, Scherbaum D, Alfer J, Juhnke BO, et al. Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta Neuropathol. 2016;132(4):635-637.  https://doi.org/10.1007/s00401-016-1608-3
  17. Jain SU, Rashoff AQ, Krabbenhoft SD, Hoelper D, Do TJ, Gibson TJ, Lundgren SM, Bondra ER, Deshmukh S, Harutyunyan AS, et al. H3 K27M and EZHIP impede H3K27-methylation spreading by inhibiting allosterically stimulated PRC2. Mol Cell. 2020;80(4): 726-735.e7.  https://doi.org/10.1016/j.molcel.2020.09.028
  18. Orillac C, Thomas C, Dastagirzada Y, Hidalgo ET, Golfinos JG, Zagzag D, Wisoff JH, Karajannis MA, Snuderl M. Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation. Acta Neuropathol Commun. 2016;4(1):84.  https://doi.org/10.1186/s40478-016-0361-0
  19. López G, Oberheim Bush NA, Berger MS, Perry A, Solomon DA. Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol Commun. 2017;5(1):38.  https://doi.org/10.1186/s40478-017-0440-x
  20. Gu Q, Huang Y, Zhang H, Jiang B. Case report: five adult cases of H3K27-altered diffuse midline glioma in the spinal cord. Front Oncol. 2021;11:701113. https://doi.org/10.3389/fonc.2021.701113
  21. Ryzhova MV, Galstyan SA, Starovoitov DV, Snigireva GP, Zubova IV, Golanov AV, Pronin IN, Pavlova GV, Mertsalova MP, Belov AI, Kalinin PL, Serova NK. Intraosseous metastasis of K27-mutant glioma. Arkhiv Patologii. 2021;83(3):40-44. (In Russ.). https://doi.org/10.17116/patol20218303140
  22. Karremann M, Gielen GH, Hoffmann M, Wiese M, Colditz N, Warmuth-Metz M, Bison B, Claviez A, van Vuurden DG, von Bueren AO, et al. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol. 2018;20(1):123-131.  https://doi.org/10.1093/neuonc/nox149
  23. La Rocca G, Sabatino G, Altieri R, Signorelli F, Ricciardi L, Gessi M, Della Pepa GM. Significance of H3K27M mutation in «nonmidline» high-grade gliomas of cerebral hemispheres. World Neurosurg. 2019;131:174-176.  https://doi.org/10.1016/j.wneu.2019.08.024
  24. Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ, Perry A. Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol. 2016;26(5):569-580.  https://doi.org/10.1111/bpa.12336
  25. Schreck KC, Ranjan S, Skorupan N, Bettegowda C, Eberhart CG, Ames HM, Holdhoff M. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neurooncol. 2019;143(1):87-93.  https://doi.org/10.1007/s11060-019-03134-x
  26. Zaitseva MA, Yas’ko LA, Papusha LI, Drui AE. Molecular genetic features of pediatric gliomas. Pediatric Hematology/Oncology and Immunopathology. 2019;18(4):109-117. (In Russ.). https://doi.org/10.24287/1726-1708-2019-18-4-109-117
  27. Mikhalevskaya TM, Kapuza DR, Konoplya NE, Bydanov OI, Aleinikova OV. Long-term outcome and surrogate molecular signatures of pediatric patients with diffuse astrocytomas. Pediatric Hematology/Oncology and Immunopathology. 2021;20(4):69-77. (In Russ.). https://doi.org/10.24287/1726-1708-2021-20-4-69-77
  28. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251. https://doi.org/10.1093/neuonc/noab106
  29. El-Ayadi M, Ansari M, Sturm D, Gielen GH, Warmuth-Metz M, Kramm CM, von Bueren AO. High-grade glioma in very young children: a rare and particular patient population. Oncotarget. 2017;8(38):64564-64578. https://doi.org/10.18632/oncotarget.18478
  30. Papusha LI, Valiakhmetova EF, Drui AE, Yas’ko LA, Voronin KA, Zaitseva MA, Sal’nikova EA, Raikina EV, Novichkova GA, Karachunskii AI. Low-grade gliomas with the V600E mutation in the BRAF gene in children: clinical features and treatment options. Pediatric Hematology/Oncology and Immunopathology. 2020;19(4):58-65. (In Russ.). https://doi.org/10.24287/1726-1708-2020-19-4-58-65
  31. Samusik NA, Galach’yants YuP, Kozlov AP. Evolutionary analysis of sequences expressed in tumors. Ecologic Genetics. 2009;7(2):26-37. (In Russ.). https://doi.org/10.17816/ecogen7226-37
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.